$0.7049
-0.0373-5.03%
Dern. MÀJ: Oct 30, 3:08 PM
Akebia Therapeutics (AKBA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.01 | $-0.05 | $-0.02 |
| Actual | $-0.03 | $-0.03 | $-0.05 | $0.00 |
| Surprise | 0.00% | -200.0% | 0.00% | +100.0% |
| Revenue | ||||
| Estimate | $49.5M | $52.6M | $47.9M | $57.5M |
| Actual | $49.1M | $53.5M | $57.6M | $58.8M |
| Surprise | -0.79% | +1.74% | +20.3% | +2.27% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.03 | $-0.03 | $-0.09 | $-0.09 |
| Revenue | ||||
| Consensus | $46.9M | $48.1M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.03 | $-0.03 | 0.00 % |
| Q1 | May 7, 2026 | $-0.03 | $-0.01 | -200.0 % |
| Q4 | Feb 26, 2026 | $-0.05 | $-0.05 | 0.00 % |
| Q3 | Nov 10, 2025 | $0 | $-0.02 | 100.0 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $49.13M | $49.52M | -0.79 % |
| Q1 | May 7, 2026 | $53.54M | $52.63M | 1.74 % |
| Q4 | Feb 26, 2026 | $57.62M | $47.89M | 20.3 % |
| Q3 | Nov 10, 2025 | $58.77M | $57.46M | 2.27 % |